BR112023022318A2 - Capsídeos de aav e seu uso - Google Patents

Capsídeos de aav e seu uso

Info

Publication number
BR112023022318A2
BR112023022318A2 BR112023022318A BR112023022318A BR112023022318A2 BR 112023022318 A2 BR112023022318 A2 BR 112023022318A2 BR 112023022318 A BR112023022318 A BR 112023022318A BR 112023022318 A BR112023022318 A BR 112023022318A BR 112023022318 A2 BR112023022318 A2 BR 112023022318A2
Authority
BR
Brazil
Prior art keywords
aav
aav capsids
capsids
pericytes
mediator
Prior art date
Application number
BR112023022318A
Other languages
English (en)
Inventor
A Maguire Casey
Eloise Hudry
S Hanlon Killian
L Musolino Patricia
Original Assignee
Massachusetts Gen Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Gen Hospital filed Critical Massachusetts Gen Hospital
Publication of BR112023022318A2 publication Critical patent/BR112023022318A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14145—Special targeting system for viral vectors

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

capsídeos de aav e seu uso. a presente invenção refere-se a peptídeos de capsídeo que atuaram como mediador da transdução eficiente de aav da vasculatura cerebral, principalmente células endoteliais e pericitos, assim como células musculares lisas, composições (incluindo aav) e métodos de uso dos mesmos.
BR112023022318A 2021-04-27 2022-04-27 Capsídeos de aav e seu uso BR112023022318A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163180320P 2021-04-27 2021-04-27
PCT/US2022/026608 WO2022232327A2 (en) 2021-04-27 2022-04-27 Aav capsids and uses thereof

Publications (1)

Publication Number Publication Date
BR112023022318A2 true BR112023022318A2 (pt) 2023-12-26

Family

ID=83847326

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023022318A BR112023022318A2 (pt) 2021-04-27 2022-04-27 Capsídeos de aav e seu uso

Country Status (9)

Country Link
EP (1) EP4330414A2 (pt)
JP (1) JP2024515807A (pt)
CN (1) CN117980488A (pt)
AU (1) AU2022266615A1 (pt)
BR (1) BR112023022318A2 (pt)
CA (1) CA3218071A1 (pt)
IL (1) IL307957A (pt)
MX (1) MX2023012722A (pt)
WO (1) WO2022232327A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023196851A1 (en) 2022-04-06 2023-10-12 President And Fellows Of Harvard College Reversing aging of the central nervous system
CN117106825A (zh) * 2023-08-28 2023-11-24 康霖生物科技（杭州）有限公司 用于治疗帕金森病的基因治疗载体及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
US20090087878A9 (en) * 1999-05-06 2009-04-02 La Rosa Thomas J Nucleic acid molecules associated with plants
CN112703198A (zh) * 2018-07-11 2021-04-23 布里格姆妇女医院 用于跨血脑屏障递送试剂的方法和组合物

Also Published As

Publication number Publication date
AU2022266615A1 (en) 2023-11-09
WO2022232327A3 (en) 2022-11-24
CA3218071A1 (en) 2022-11-03
WO2022232327A9 (en) 2023-08-17
IL307957A (en) 2023-12-01
EP4330414A2 (en) 2024-03-06
MX2023012722A (es) 2023-11-08
CN117980488A (zh) 2024-05-03
WO2022232327A2 (en) 2022-11-03
JP2024515807A (ja) 2024-04-10

Similar Documents

Publication Publication Date Title
BR112023022318A2 (pt) Capsídeos de aav e seu uso
MX2021013267A (es) Nuevas capsides de aav y composiciones que las contienen.
EP4219696A3 (en) Oncolytic virus strain
CL2020000728A1 (es) Variantes de cápsides de virus adenoasociados y métodos de uso de estas.
CL2020000991A1 (es) Proteínas trispecíficas y métodos de uso.
CL2020001360A1 (es) Cápsides variantes de virus adenoasociados y su uso para inhibir la angiogénesis.
NZ701693A (en) Composition and methods for highly efficient gene transfer using aav capsid variants
CL2022002359A1 (es) Constructos moleculares para disminuir la expresión de las proteínas ga3 oxidasa y métodos relacionados (divisional de solicitud 2242-2020)
CO2018008427A2 (es) Conjugado de enzimas terapéuticas
MA34909B1 (fr) Triterpénoïdes modifi2s en c-17 et c-3 presentant une activité inhibitrice de la maturation du vih
UY37863A (es) Virus adenoasociado (aav) con dominio de fosfolipasa modificado
MA40843A (fr) Compositions d'arni contre le virus de l'hépatite delta et procédés d'utilisation de celles-ci
EA201891415A8 (ru) Антигены вируса иммунодефицита человека, векторы, композиции и способы их применения
BRPI0510665A (pt) 3-(4-heteroarilcicloexilamino) ciclopentano-carboxiamidas como moduladores de receptores de quimiocinas
GT201100023A (es) Anticuerpos neutralizantes del virus anti - influenza a y usos de los mismos
EA202091712A1 (ru) МОДИФИЦИРОВАННЫЙ КАПСИДНЫЙ БЕЛОК rAAV ДЛЯ ГЕННОЙ ТЕРАПИИ
BR112022022608A2 (pt) Compostos como inibidores de bcl-2
MX2023001863A (es) Nuevas cápsides de aav y composiciones que las contienen.
EA201891919A1 (ru) Способы трансфекции растений и сокращения событий случайной интеграции
AR114551A1 (es) COMPOSICIONES DE AGENTES DE ARNhd CONTRA EL VIRUS DE HEPATITIS B (HBV) Y MÉTODOS PARA SU USO
CL2018001279A1 (es) Spodoptera frugiperda resistente a vip3a.
EA202192084A1 (ru) Композиции и способы для лечения связанных с тревожностью нарушений
CO2022010227A2 (es) Proteínas de la cápside de virus adeno-asociados modificadas para la terapia génica ocular y métodos de uso de las mismas
BR112021025317A2 (pt) Tienilhidroxiisoxazolinas e derivados das mesmas
AR119869A1 (es) Proteína vp1 modificada aislada de la cápside del virus adeno-asociado de serotipo 5 (aav5), cápside y vector basado en la misma